Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Mol Med. 2002 Jul;8(7):330-4.

PEDF: anti-angiogenic guardian of ocular function.

Author information

1
Dept of Microbiology-Immunology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, 310 East Superior Street, Chicago, Il 60611, USA. n.bouck@northwestern.edu

Abstract

Sight-threatening eye diseases can be caused and exacerbated by the aberrant growth of new blood vessels. Recent work indicates that this neovascularization not only is a response to a rise in the local concentration of molecules that induce such angiogenesis but also requires a fall in the levels of endogenous molecules that inhibit angiogenesis. One of the most potent of these endogenous inhibitors is pigment epithelium-derived factor (PEDF), which serves as a survival factor for neuronal components of the eye as well as an essential inhibitor of the growth of ocular blood vessels. Its anti-angiogenic activity is selective in that it is effective against newly forming vessels but spares existing ones, and it is reversible. The molecular basis for this delicate control of endothelial cells is beginning to be understood and strategies to test the ability of PEDF to ameliorate or prevent vessel damage in the eye are developing rapidly.

PMID:
12114112
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center